Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1007777

registered interest
date	15/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will introduce a secondary support package covering breast cancer care to include (a) access to a dedicated clinical nurse specialist, (b) an assessment of physical and emotional needs at (i) diagnosis and (ii) through treatment and referral and (c) signposting to tailored, specialist support services.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	191871
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The NHS Cancer Programme is working to improve access to cancer nurse specialists (CNSs) for all cancer patients when they need it, including those with secondary breast cancer.</p><p> </p><p>We are committed to rolling out the recovery package to every cancer patient by 2020. The recovery package is a set of four interventions designed to help patients and clinicians assess a patient’s holistic needs, including physical and emotional needs, at appropriate time points through their cancer journey, as needs do change especially when a person is diagnosed with secondary cancer. A personalised care and support plan to meets these needs should be agreed, ensuring signposting and referral to the right support and care services is made, and also helping to empower patients to independently manage their own health, with advice and support.</p><p> </p><p>NHS England is committed to giving more patients access to a CNS or other specialist from diagnosis onwards to guide them through treatment options and ensure they receive appropriate information and support. In their first Cancer Workforce Plan, which was published in December 2017, Health Education England committed to supporting the expansion of CNSs by developing national competencies and a clear route into training. This will ensure that every patient has access to a CNS or other support worker by 2021.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 15:20:10 answering member 4067 label Biography information for Steve Brine
tabling member	478 label Biography information for Lord Field of Birkenhead

1006964

registered interest
date	14/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ocrelizumab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the affordability to the NHS of ocrelizumab for the treatment of progressive multiple sclerosis.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	191304
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>The Department has made no assessment. The National Institute for Health and Care Excellence is currently developing technology appraisal guidance on the use of ocrelizumab for treating primary progressive multiple sclerosis.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 11:48:19 answering member 4067 label Biography information for Steve Brine
tabling member	478 label Biography information for Lord Field of Birkenhead

1006994

registered interest
date	14/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	AAT Deficiency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he take steps to make available intravenous alpha-1 augmentation therapy through the NHS to treat alpha-1.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	191306
answer	answer is ministerial correction date of answer 21/11/2018 answer text <p>NHS England is engaging with the National Institute for Health and Care Excellence (NICE) on the Highly Specialised Technologies evaluation of human alpha1-proteinase inhibitor for treating emphysema in adults with documented severe alpha1 antitrypsin deficiency. NICE has not yet published final guidance and recently consulted on its draft guidance.</p><p> </p><p>NICE’s evaluation committee is due to meet again to consider its recommendations in spring next year. This is to enable the company that makes the alpha1-proteinase inhibitor to prepare and submit additional information for consideration by the committee. Once NICE guidance is received, NHS England will then consider the commissioning implications in consultation with the Specialised Respiratory Clinical Reference Group.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 21/11/2018 14:37:29 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	478 label Biography information for Lord Field of Birkenhead

1006995

registered interest
date	14/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	AAT Deficiency
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when he plans a NHS service for alpha-1 to improve patients' access to coordinated multi-disciplinary clinical expertise, which was approved by the Department's Prescribed Specialised Services Advisory Group in March 2016, to commence.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	191307
answer	answer is ministerial correction date of answer 21/11/2018 answer text <p>The Specialised Respiratory Clinical Reference Group (CRG) is maintaining an oversight of the need to develop a service specification and selection of providers to offer specialised expertise and management advice for patients diagnosed with alpha1 antitrypsin deficiency (AATD).</p><p> </p><p>The CRG has recommended that NHS England wait until it is clear on the outcome of the National Institute for Health and Care Excellence (NICE) Highly Specialised Technologies evaluation of human alpha1-proteinase inhibitor for treating emphysema in adults with documented severe AATD [ID856] until this development is taken forward.</p><p> </p><p>NICE has not yet published final guidance and recently consulted on its draft guidance. NICE’s evaluation committee is due to meet again to consider its recommendations in spring next year. This is to enable the company that makes the alpha1-proteinase inhibitor to prepare and submit additional information for consideration by the committee.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 21/11/2018 14:39:19 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	478 label Biography information for Lord Field of Birkenhead

1007006

registered interest
date	14/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ovarian Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department has taken to improve early diagnosis of ovarian cancer.
tabling member constituency	Birkenhead
tabling member printed	Frank Field
uin	191308
answer	answer is ministerial correction date of answer 22/11/2018 answer text <p>Public Health England (PHE) has run a number of ‘Be Clear on Cancer’ (BCOC) campaigns to help improve early detection of cancer. In 2014 PHE ran a regional ovarian cancer campaign in the North West of England, and in 2017 a pilot which focussed on a range of abdominal symptoms, such as diarrhoea, bloating and discomfort that can be indicative of a number of cancers, including ovarian cancer was carried out in the East and West Midlands. PHE is currently undertaking new data analysis and research to determine the future direction of BCOC activity in 2019/20 and will take into consideration the outcomes of these previous campaigns. PHE will also consult with NHS England on the timings and location of any future campaigns.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/11/2018 11:44:06 answering member 4067 label Biography information for Steve Brine
tabling member	478 label Biography information for Lord Field of Birkenhead